Article Details
Retrieved on: 2022-11-04 07:51:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Mizuho raised their price target on shares of Unity Biotechnology from $70.00 to $80.00 and gave the company a “buy” rating in a research report on ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here